Target definition in salvage postoperative radiotherapy for prostate cancer: 18F-fluorocholine PET/CT assessment of local recurrence

References

• Stephenson AJ, Scardino PT, Kattan MW, et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol. 2007;25:2035–2041.
   PubMed Web of Science ®Google Scholar
• Aus G, Abbou CC, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol. 2005;48:546–551.
   PubMed Web of Science ®Google Scholar
• Ploussard G, Agamy MA, Alenda O, et al. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naive patients. BJU Int. 2011;107:1748–1754.
   PubMed Web of Science ®Google Scholar
• Michalski JM, Lawton C, El Naqa I, et al. Development of RTOG consensus guidelines for the definition of the clinical target volume for postoperative conformal radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2010;76:361–368.
   PubMed Web of Science ®Google Scholar
• Poortmans P, Bossi A, Vandeputte K, et al. Guidelines for target volume definition in post-operative radiotherapy for prostate cancer, on behalf of the EORTC Radiation Oncology Group. Radiother Oncol. 2007;84:121–127.
   PubMed Web of Science ®Google Scholar
• Miralbell R, Vees H, Lozano J, et al. Endorectal MRI assessment of local relapse after surgery for prostate cancer: a model to define treatment field guidelines for adjuvant radiotherapy in patients at high risk for local failure. Int J Radiat Oncol Biol Phys. 2007;67:356–361.
   PubMed Web of Science ®Google Scholar
• Wiltshire KL, Brock KK, Haider MA, et al. Anatomic boundaries of the clinical target volume (prostate bed) after radical prostatectomy. Int J Radiat Oncol Biol Phys. 2007;69:1090–1099.
   PubMed Web of Science ®Google Scholar
• Sidhom MA, Kneebone AB, Lehman M, et al. Post-prostatectomy radiation therapy: consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group. Radiother Oncol. 2008;88:10–19.
   PubMed Web of Science ®Google Scholar
• Mitchell CR, Lowe VJ, Rangel LJ, et al. Operational characteristics of (11)c-choline positron emission tomography/computerized tomography for prostate cancer with biochemical recurrence after initial treatment. J Urol. 2013;189:1308–1313.
   PubMed Web of Science ®Google Scholar
• Evangelista L, Cimitan M, Hodolic M, et al. The ability of 18F-choline PET/CT to identify local recurrence of prostate cancer. Abdom Imaging. 2015;40:3230–3237.
   PubMedGoogle Scholar
• Vali R, Loidl W, Pirich C, et al. Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine. Am J Nucl Med Mol Imaging. 2015;5:96–108.
   PubMed Web of Science ®Google Scholar
• Geets X, Lee JA, Bol A, et al. A gradient-based method for segmenting FDG-PET images: methodology and validation. Eur J Nucl Med Mol Imaging. 2007;34:1427–1438.
   PubMed Web of Science ®Google Scholar
• Wang J, Kudchadker R, Choi S, et al. Local recurrence map to guide target volume delineation after radical prostatectomy. Pract Radiat Oncol. 2014;4:e239–e246.
   PubMedGoogle Scholar
• Connolly JA, Shinohara K, Presti JC Jr, et al. Local recurrence after radical prostatectomy: characteristics in size, location, and relationship to prostate-specific antigen and surgical margins. Urology. 1996;47:225–231.
   PubMed Web of Science ®Google Scholar
• Croke J, Malone S, Roustan Delatour N, et al. Postoperative radiotherapy in prostate cancer: the case of the missing target. Int J Radiat Oncol Biol Phys. 2012;83:1160–1168.
   PubMed Web of Science ®Google Scholar
• Malone S, Croke J, Roustan-Delatour N, et al. Postoperative radiotherapy for prostate cancer: a comparison of four consensus guidelines and dosimetric evaluation of 3D-CRT versus tomotherapy IMRT. Int J Radiat Oncol Biol Phys. 2012;84:725–732.
   PubMed Web of Science ®Google Scholar
• Croke J, Maclean J, Nyiri B, et al. Proposal of a post-prostatectomy clinical target volume based on pre-operative MRI: volumetric and dosimetric comparison to the RTOG guidelines. Radiat Oncol. 2014;9:303.
   PubMedGoogle Scholar
• Evangelista L, Zattoni F, Guttilla A, et al. Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. Clin Nucl Med. 2013;38:305–314.
   PubMed Web of Science ®Google Scholar
• Kanoun SWP, Vrigneaud JM, Depardon E, et al. 18F-Choline PET/CT and multiparametric MRI for the detection of early local recurrence of prostate cancer initially treated by radiotherapy: comparison with systematic 3D-transperineal mapping biopsy. Int J Radiat Oncol Biol Phys. 2017;97:986–994.
   PubMed Web of Science ®Google Scholar
• Abgral R, Keromnes N, Robin P, et al. Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma. Eur J Nucl Med Mol Imaging. 2014;41:659–667.
   PubMed Web of Science ®Google Scholar
• Daisne JF, Sibomana M, Bol A, et al. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol. 2003;69:247–250.
   PubMed Web of Science ®Google Scholar
• Wang H, Vees H, Miralbell R, et al. 18F-fluorocholine PET-guided target volume delineation techniques for partial prostate re-irradiation in local recurrent prostate cancer. Radiother Oncol. 2009;93:220–225.
   PubMed Web of Science ®Google Scholar
• Wanet M, Lee JA, Weynand B, et al. Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: a comparison with threshold-based approaches, CT and surgical specimens. Radiother Oncol. 2011;98:117–125.
   PubMed Web of Science ®Google Scholar